During the past decade, Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion" are "Crohn's Disease" (2 trials), "Chronic Idiopathic Constipation" (1 trials), "Constipation" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion" in a lesser frequency.

Most popular intervention types in "Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Elobixibat 10 mg/day" (1 trials), "Elobixibat 5 mg/day" (1 trials), "PF-00547659" (1 trials) and "PF-00547659 SC injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lama Medical Care s.r.o., Gastroentero-hepatologicke centrum Thalion, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".